MOH
- Marketing authorisation holder: GLAXOSMITHKLINE
- Status: likely_approved
🇮🇱 Blujepa in Israel
Blujepa (GEPOTIDACIN) regulatory status in Israel.
Marketing authorisation
Blujepa in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Infectious Disease approved in Israel
Frequently asked questions
Is Blujepa approved in Israel?
Yes. MOH has authorised it.
Who is the marketing authorisation holder for Blujepa in Israel?
GLAXOSMITHKLINE holds the Israeli marketing authorisation.